feed,title,long_url,short_url
Benzinga,Sanofi provides update on KevzaraÂ® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S,https://www.benzinga.com/pressreleases/20/09/g17322079/sanofi-provides-update-on-kevzara-sarilumab-phase-3-trial-in-severe-and-critically-ill-covid-19-pa,https://j.mp/3lySvyZ
